Oaktree Acquisition Corp III Life Sciences

OACCFinancial·Shell Companies·USA·Micro·NASD·Nov 11 • 10:31 AM ET

10.670.00 (0.00%)

2026-11-12 04:08 CET

Market cap

263.04 USD m

Revenue, TTM

0.00 USD m

Net income, TTM

6.75 USD m

Free cash flow, TTM

-0.46 USD m

EPS diluted, TTM

0.27

P/E

38.83

Compare

Price

OACC against its 20, 50 and 200-day averages

2050200

2.4% under the 52-week high of 10.93 on 14 Oct 2026. 52-week low 10.30 on 15 Aug 2025. Last 15 sessions, 0.9% high to low

the line is the 50-bar volume average

Profile

OACC

52-week range, 40% of the way up

10.5010.93

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Employees	3
IPO	Dec 16, 2024
Beta	0.01
ATR, 14d	0.04
Rel volume	0.00
Short float	0.01%
Insider own	19.52%
Inst own	98.00%

Snapshot

6 groups

Valuation

Index	-
Market Cap	263.28M
Enterprise Value	262.11M
Income	6.75M
Sales	0.00M
Book/sh	8.05
Cash/sh	0.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	3
IPO	Dec 16, 2024

Ratios

P/E	38.83
Forward P/E	-
PEG	-
P/S	-
P/B	1.33
P/C	223.12
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.73
Current Ratio	0.73
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

Earnings

EPS (ttm)	0.27
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	39.00%
Sales Y/Y TTM	-
EPS Q/Q	-14.30%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Ownership

Insider Own	19.52%
Insider Trans	0.00%
Inst Own	98.00%
Inst Trans	-
ROA	3.33%
ROE	3.47%
ROIC	3.41%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-0.38%
SMA50	-0.66%
SMA200	0.26%
Trades	-

Technical

Shs Outstand	19.78M
Shs Float	19.78M
Short Float	0.01%
Short Ratio	0.03
Short Interest	0.00M
52W High	10.93 -2.38%
52W Low	10.50 1.62%
Volatility	0.13% 0.19%
ATR (14)	0.04
RSI (14)	43.60
Beta	0.01
Rel Volume	0.00
Avg Volume	42.25K
Volume	14

Performance

Perf Week	-0.47%
Perf Month	-0.74%
Perf Quarter	-1.20%
Perf Half Y	0.28%
Perf YTD	0.85%
Perf Year	0.66%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.67
Price	10.67
Change %	0.00%

Key figures

Revenue, TTM	0.00
Net income, TTM	6.75
EPS diluted, TTM	0.27
EBIT, TTM	-1.20
Free cash flow, TTM	-0.46
Gross margin	-%
Operating margin	-%
Net margin	-%
Market cap	263.04
P/E	38.83
Sales Y/Y, TTM	-

USD millions. TTM from the statement feed.

Quarterly earnings

actual against estimate

Period	Reported	EPS act	EPS est	EPS rep	Sales act	Sales est	Analysts
No quarterly earnings.

Period

Reported

EPS act

EPS est

EPS rep

Sales act

Sales est

Analysts

No quarterly earnings.

Annual earnings

Period	EPS act	EPS est	EPS rep	Sales act	Sales est
No annual earnings.

Period

EPS act

EPS est

EPS rep

Sales act

Sales est

No annual earnings.

Estimate revisions

last 14 periods

Period	Type	Date	Estimates	Up	Down	Mean	Low	High
No estimate revisions.

Period

Type

Date

Estimates

Down

Mean

Low

High

No estimate revisions.

Estimate history

Period	2024	2025	TTM
EPS, annual	0.054	0.297	0.2748
EPS, quarterly	-0.002	0.056	0.068	0.076	0.08	0.073	0.057	0.065
Period	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Sales, annual	0	0	0
Period	2024	2025	TTM
Sales, quarterly	0	0	0	0	0	0	0	0
Period	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Shares, annual	24.583	24.583	24.583
Period	2024	2025	MRQ
Shares, quarterly	22.425	24.583	24.583	24.583	24.583	24.583	24.583	24.583
Period	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26

Income statement, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY
Total Revenue	0.00	0.00	0.00
Cost of Goods Sold Incl. D&A	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00
Selling, General and Administrative Excl. Other	1.20	1.20	0.35
Other Operating Expense	0.00	0.00	0.00
Operating Income	-1.20	-1.20	-0.35
Unusual Expense	0.00	0.00	-0.09
Net Income Before Taxes	6.75	7.29	1.33
Income Taxes	0.00	0.00	0.00
Consolidated Net Income	6.75	7.29	1.33
Net Income From Continuing Operations	6.75	7.29	1.33
Net Income	6.75	7.29	1.33
EPS (Recurring)	0.27	0.30	0.05
EPS (Basic, Before Extraordinaries)	0.27	0.30	0.05
EPS (Diluted)	0.27	0.30	0.05
EBITDA	-1.20	-1.20	-0.35
Non-Operating Income (Expense)	7.95	8.48	1.59
Other After Tax Adjustments	0.00	0.00	0.00
Price To Earnings Ratio	38.94	38.94	-
Shares Outstanding	24.58	24.58	24.58
Market Capitalization	263.04	263.04	223.35

Income statement, quarterly

Currency USD, millions
Metric	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3
Total Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of Goods Sold Incl. D&A	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General and Administrative Excl. Other	0.26	0.46	0.26	0.23	0.27	0.44	0.30	0.05
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	-0.26	-0.46	-0.26	-0.23	-0.27	-0.44	-0.30	-0.05
Unusual Expense	0.00	0.00	0.00	0.00	0.00	0.00	-0.09	0.00
Net Income Before Taxes	1.60	1.39	1.79	1.97	1.87	1.66	1.38	-0.05
Income Taxes	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Consolidated Net Income	1.60	1.39	1.79	1.97	1.87	1.66	1.38	-0.05
Net Income From Continuing Operations	1.60	1.39	1.79	1.97	1.87	1.66	1.38	-0.05
Net Income	1.60	1.39	1.79	1.97	1.87	1.66	1.38	-0.05
EPS (Recurring)	0.07	0.06	0.07	0.08	0.08	0.07	0.05	-0.00
EPS (Basic, Before Extraordinaries)	0.07	0.06	0.07	0.08	0.08	0.07	0.06	-0.00
EPS (Diluted)	0.07	0.06	0.07	0.08	0.08	0.07	0.06	-0.00
EBITDA	-0.26	-0.46	-0.26	-0.23	-0.27	-0.44	-0.30	-0.05
Non-Operating Income (Expense)	1.87	1.85	2.04	2.19	2.14	2.10	1.59	0.00
Other After Tax Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price To Earnings Ratio	38.94	35.68	37.80	-	-	-	-	-
Shares Outstanding	24.58	24.58	24.58	24.58	24.58	24.58	24.58	22.43
Market Capitalization	263.04	260.09	260.09	258.37	256.89	251.48	223.35	223.58

Balance sheet, annual

Currency USD, millions
Metric	2025FY	2024FY
Cash & Short Term Investments	1.43	1.36
Short Term Receivables	0.00	0.00
Inventories	0.00	0.00
Other Current Assets	0.11	0.20
Total Current Assets	1.55	1.56
Net Property, Plant & Equipment	0.00	0.00
Total Investments and Advances	201.56	193.58
Intangible Assets	0.00	0.00
Other Assets	0.00	0.11
Total Assets	203.11	195.25
Short Term Debt Incl. Current Port. of LT Debt	0.01	0.01
Accounts Payable	0.00	0.00
Other Current Liabilities	1.29	0.72
Total Current Liabilities	1.30	0.73
Long Term Debt	0.00	0.00
Provision for Risks Charges	0.00	0.00
Other Liabilities	7.02	7.02
Total Liabilities	8.32	7.75
Non-Equity Reserves	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00
Common Equity	194.79	187.50
Total Shareholders Equity	194.79	187.50
Accumulated Minority Interest	0.00	0.00
Total Equity	194.79	187.50
Total Liabilities & Stockholders Equity	203.11	195.25
Book Value Per Share	7.92	7.63
Tangible Book Value Per Share	7.92	7.63
Full-Time Employees	3	3
Price to Book Ratio	1.33	-9,669.90
Return on Assets	3.66	-
Return on Equity	3.81	-
Return on Invested Capital	3.74	0.71
Quick Ratio	1.19	2.14
Current Ratio	1.19	2.14

Cash flow, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY
Net Income	6.75	7.29	1.33
Other Funds (Non Cash)	-7.95	-8.48	-1.64
Funds from Operations	-1.20	-1.20	-0.31
Extraordinary Item	0.00	0.00	0.00
Changes in Working Capital	0.74	0.77	0.22
Cash from Operating Activities	-0.46	-0.42	-0.09
Capital Expenditures	0.00	0.00	0.00
Net Assets From Acquisitions	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00
Purchase or Sale of Investments	0.00	0.00	-191.99
Purchase of Investments	0.00	0.00	-191.99
Sale Or Maturity of Investments	0.00	0.00	0.00
Other Uses	0.00	0.00	0.00
Other Sources	0.25	0.50	0.00
Cash from Investing Activities	0.25	0.50	-191.99
Cash Dividends Paid	0.00	0.00	0.00
Change in Capital Stock	0.00	0.00	193.99
Repurchase of Common Pref Stock	0.00	0.00	0.00
Sale of Common Pref Stock	0.00	0.00	193.99
Proceedsfrom Stock Options	0.00	0.00	193.99
Issuance or Reduction of Debt, Net	0.00	0.00	-0.55
Change in Long Term Debt	0.00	0.00	0.00
Issuance of Long Term Debt	0.00	0.00	0.00
Reduction of Long Term Debt	0.00	0.00	0.00
Net Financing Active Other Cash Flow	0.00	0.00	0.00
Other Financing Activities Uses	0.00	0.00	0.00
Cash from Financing Activities	0.00	0.00	193.44
Net Change in Cash	-0.21	0.08	1.36
Free Cash Flow	-0.46	-0.42	-0.09
Preferred Dividends (Cash Flow)	-	0.00	0.00
Deferred Taxes & Investment Tax Credit	-	0.00	0.00

Balance sheet, quarterly

Currency USD, millions
Metric	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1
Cash & Short Term Investments	1.18	1.28	1.43	1.33	1.39	1.28
Short Term Receivables	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.08	0.14	0.11	0.15	0.18	0.20
Total Current Assets	1.26	1.42	1.55	1.48	1.56	1.48
Net Property, Plant & Equipment	0.00	0.00	0.00	0.00	0.00	0.00
Total Investments and Advances	205.28	203.41	201.56	199.77	197.58	195.68
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.00	0.00	0.00	0.00	0.04	0.08
Total Assets	206.54	204.83	203.11	201.25	199.18	197.24
Short Term Debt Incl. Current Port. of LT Debt	0.01	0.01	0.01	0.01	0.01	0.01
Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	1.72	1.61	1.29	1.21	1.11	1.05
Total Current Liabilities	1.73	1.62	1.30	1.23	1.12	1.06
Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	7.02	7.02	7.02	7.02	7.02	7.02
Total Liabilities	8.75	8.64	8.32	8.25	8.14	8.08
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00	0.00	0.00
Common Equity	197.79	196.19	194.79	193.00	191.04	189.16
Total Shareholders Equity	197.79	196.19	194.79	193.00	191.04	189.16
Accumulated Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity	197.79	196.19	194.79	193.00	191.04	189.16
Total Liabilities & Stockholders Equity	206.54	204.83	203.11	201.25	199.18	197.24
Book Value Per Share	8.05	7.98	7.92	7.85	7.77	7.69
Tangible Book Value Per Share	8.05	7.98	7.92	7.85	7.77	7.69
Full-Time Employees	-	-	3	-	-	-
Price to Book Ratio	1.33	1.34	1.35	1.35	1.36	1.34
Return on Assets	3.33	3.49	3.66	6.82	-	-
Return on Equity	3.47	3.65	3.81	7.13	-	-
Return on Invested Capital	0.81	0.71	0.92	1.02	0.98	0.88
Quick Ratio	0.73	0.87	1.19	1.21	1.39	1.40
Current Ratio	0.73	0.87	1.19	1.21	1.39	1.40

Cash flow, quarterly

Currency USD, millions
Metric	2026Q2	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1
Net Income	1.60	1.39	1.79	1.97	1.87	1.66
Other Funds (Non Cash)	-1.87	-1.85	-2.04	-2.19	-2.14	-2.10
Funds from Operations	-0.26	-0.46	-0.26	-0.23	-0.27	-0.44
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	0.16	0.30	0.11	0.17	0.12	0.37
Cash from Operating Activities	-0.10	-0.16	-0.14	-0.06	-0.15	-0.08
Capital Expenditures	0.00	0.00	0.00	0.00	0.00	0.00
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.00	0.00	0.00
Purchase or Sale of Investments	0.00	0.00	0.00	0.00	0.00	0.00
Purchase of Investments	0.00	0.00	0.00	0.00	0.00	0.00
Sale Or Maturity of Investments	0.00	0.00	0.00	0.00	0.00	0.00
Other Uses	0.00	0.00	0.00	0.00	0.00	0.00
Other Sources	0.00	0.00	0.25	0.00	0.25	0.00
Cash from Investing Activities	0.00	0.00	0.25	0.00	0.25	0.00
Cash Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Dividends (Cash Flow)	0.00	0.00	0.00	0.00	0.00	0.00
Change in Capital Stock	0.00	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00
Proceedsfrom Stock Options	0.00	0.00	0.00	0.00	0.00	0.00
Issuance or Reduction of Debt, Net	0.00	0.00	0.00	0.00	0.00	0.00
Change in Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Issuance of Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Reduction of Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Net Financing Active Other Cash Flow	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities Uses	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	0.00	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	-0.10	-0.16	0.11	-0.06	0.10	-0.08
Free Cash Flow	-0.10	-0.16	-0.14	-0.06	-0.15	-0.08

Revenue breakdown

Revenue split	-

Short interest

shares short against float, oldest to newest

Settlement	Of float	Shares short	Float	Avg volume
2026-10-30	0.01%	0.0M	19.8M	49.30K
2026-10-15	0.00%	0.0M	19.8M	62.41K
2026-09-30	0.00%	0.0M	19.8M	44.63K
2026-09-15	0.00%	0.0M	19.8M	51.06K
2026-08-31	0.01%	0.0M	19.8M	44.05K
2026-08-14	0.04%	0.0M	19.8M	41.30K
2026-07-31	0.05%	0.0M	19.8M	38.87K
2026-07-15	0.06%	0.0M	19.8M	22.36K
2026-06-30	0.06%	0.0M	19.8M	29.04K
2026-06-15	0.14%	0.0M	19.8M	21.89K
2026-05-29	0.14%	0.0M	19.8M	37.50K
2026-05-15	0.14%	0.0M	19.8M	39.32K
2026-04-30	0.14%	0.0M	19.8M	38.10K
2026-04-15	0.14%	0.0M	19.8M	43.43K
2026-03-31	0.25%	0.0M	19.8M	47.60K
2026-03-13	0.25%	0.1M	19.8M	51.22K
2026-02-27	0.25%	0.1M	19.8M	35.57K
2026-02-13	0.25%	0.1M	19.8M	49.78K
2026-01-30	0.20%	0.0M	19.8M	48.39K
2026-01-15	0.26%	0.1M	19.8M	46.35K

Option chain

expiry 2026-11-11

Type	Strike	Bid	Ask	Last	IV	Open int	Volume	Delta	Theta	Vega
No option chain for this symbol.

Type

Strike

Bid

Ask

Last

Open int

Volume

Delta

Theta

Vega

No option chain for this symbol.

Latest SEC filings

Filed	Form	Description	Period	Link
2026-10-26	8-K	Current report	2026-10-23	SEC
2026-10-23	4	Statement of changes in beneficial ownership of securities	2026-10-23	SEC
2026-10-16	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-16	8-K	Current report	2026-10-16	SEC
2026-10-15	DEFA14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934		SEC
2026-10-15	8-K	Current report	2026-10-14	SEC
2026-10-02	DEF 14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934	2026-10-16	SEC
2026-09-21	PRE 14A	Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934	2026-09-21	SEC
2026-08-14	SCHEDULE 13G			SEC
2026-08-13	SCHEDULE 13G			SEC
2026-08-12	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-06-30	SEC
2026-05-15	SCHEDULE 13G			SEC
2026-05-13	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-03-31	SEC
2026-05-11	SCHEDULE 13G			SEC
2026-03-26	10-K	Annual report pursuant to Section 13 or 15(d)	2025-12-31	SEC
2026-02-11	SCHEDULE 13G/A			SEC
2025-11-13	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2025-09-30	SEC
2025-10-29	3	Initial statement of beneficial ownership of securities	2025-10-29	SEC
2025-10-29	8-K	Current report	2025-10-29	SEC
2025-10-22	3	Initial statement of beneficial ownership of securities	2025-10-17	SEC
2025-10-17	8-K	Current report	2025-10-17	SEC
2025-08-12	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2025-06-30	SEC
2025-08-12	SCHEDULE 13G/A			SEC
2025-07-15	SCHEDULE 13G/A			SEC
2025-06-16	3	Initial statement of beneficial ownership of securities	2025-06-03	SEC
2025-06-06	8-K	Current report	2025-06-03	SEC
2025-05-14	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2025-03-31	SEC
2025-05-14	SCHEDULE 13G/A			SEC
2025-05-14	SCHEDULE 13G/A			SEC
2025-05-13	SCHEDULE 13G			SEC

Insider activity by month

Month	Bought	Buys	Sold	Sells
2026-11	0	0	0	0
2026-10	0	0	0	0
2026-09	0	0	0	0
2026-08	0	0	0	0
2026-07	0	0	0	0
2026-06	0	0	0	0
2026-05	0	0	0	0
2026-04	0	0	0	0
2026-03	0	0	0	0
2026-02	0	0	0	0
2026-01	0	0	0	0
2025-12	0	0	0	0
2025-11	0	0	0	0

Institutional holders

Manager	% owned
AQR Arbitrage LLC	5.39%
Fort Baker Capital Management LP	4.50%
Decagon Asset Management LLP	4.44%
Empyrean Capital Partners, LP	3.66%
D. E. Shaw & Co., Inc.	3.50%
BOUSSARD & GAVAUDAN GESTION SAS	2.93%
LINDEN ADVISORS LP	2.44%
TORONTO DOMINION BANK	2.25%
Sculptor Capital LP	2.16%
GOLDMAN SACHS GROUP INC	2.15%

Funds

Fund	% owned
Horizon Kinetics SPAC Active ETF	0.20%
Fidelity Nasdaq Composite Index Fund	0.06%
Special Opportunities Fund, Inc.	0.05%

OakChart. OACC. Cached 15 minutes.

Some panels did not load: ratings, insider, news.